Specialist finance firm Oxford Lane Capital Corp. has now completed its previously announced 1-for-5 reverse stock split. The closed-end fund, which focuses on collateralized loan obligation (CLO) investments, began trading on a consolidated basis, with every five pre-split shares now representing one new share. This strategic move is designed to enhance the stock’s trading profile and broaden its appeal to a more institutional investor base.
In a corresponding action, the company has made proportional adjustments to its monthly dividend distributions. This ensures that the total cash payout per shareholder remains consistent, despite the reduced number of shares outstanding. The revised dividend schedule for the upcoming months is as follows:
- September 2025: $0.45 per share (previously $0.09)
- October 2025: $0.40 per share (previously $0.08)
- November 2025: $0.40 per share (previously $0.08)
- December 2025: $0.40 per share (previously $0.08)
Consequently, investors will receive an equivalent aggregate dividend payment as they would have prior to the share consolidation.
Should investors sell immediately? Or is it worth buying Oxford Lane Capital?
This corporate action follows a challenging quarterly report released in July. The period was marked by an 11% reduction in the dividend and a decline in the net asset value (NAV) per share, which fell from $4.32 to $4.12. This NAV contraction highlights the ongoing pressures within the current interest rate environment, which continues to challenge the CLO market.
Amid these headwinds, management has been active in deploying its capital return strategy. The company initiated a substantial $150 million share repurchase program in early 2025. By August, a portion of this authorization had already been utilized, with 4.9 million shares bought back for a total of $17.4 million, reflecting an average price of $3.53 per share.
The critical question for the market is whether the reverse split can successfully rejuvenate the equity. While a higher post-split share price can potentially attract institutional investors who often avoid lower-priced securities, the strategy’s ultimate success is intrinsically tied to the performance of Oxford Lane’s underlying CLO portfolio. Its future trajectory remains dependent on the broader interest rate landscape and the health of the credit markets.
Ad
Oxford Lane Capital Stock: Buy or Sell?! New Oxford Lane Capital Analysis from September 9 delivers the answer:
The latest Oxford Lane Capital figures speak for themselves: Urgent action needed for Oxford Lane Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 9.
Oxford Lane Capital: Buy or sell? Read more here...